With this latest announcement, Lilly has committed to investing more than $50 billion in U.S. manufacturing since 2020.

Pfizer CEO Albert Bourla on Monday said that the company might move overseas manufacturing to its existing plants in the ...

(Reuters) -Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in ...

Eli Lilly and Company, UnitedHealth Group, AbbVie, Walmart, Johnson & Johnson, Natera, and Gilead Sciences are the seven Medical stocks to watch today, according to MarketBeat’s stock screener tool.

More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...

Brands That Matter panel to examine Purdue-led pharmaceutical transformations ...

LEQEMBI (lecanemab) has significant market potential due to the high global prevalence of the condition and the demand for disease-modifying treatmen ...

AbbVie ABBV announced that it has entered into a licensing agreement with Denmark-based biotech Gubra for the latter’s ...

By Wendy Johnson, Charles City; Carmen and Maja Black, Solon; Jason and Hannah Grimm, Williamsburg; and Emma and Marcus Johnson, Central City Iowa Capital Dispatch Guest Contributors We said the ...

Over 30 state attorneys general including in Indiana, Kentucky, and Ohio have urged the Federal Food and Drug Administration ...

As biopharma players continue to parse out what the second Trump administration means for the industry, Pfizer CEO Albert ...

Gov. Gavin Newsom has yet to make good on his promise of state-produced, affordable insulin for diabetics. What's the hold up ...